These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3590069)

  • 41. [Importance of knowledge of information on adverse effects and interactions of drugs].
    Stanimirović V; Babić M; Cucak S; Nikolić D; Nikolić A
    Srp Arh Celok Lek; 2000; 128(3-4):135-9. PubMed ID: 10932625
    [No Abstract]   [Full Text] [Related]  

  • 42. Strategy for surveillance of adverse drug events.
    Bright RA
    Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
    [No Abstract]   [Full Text] [Related]  

  • 43. [Adverse drug reaction surveillance in pediatric and adult patients in an emergency room].
    Muñoz MJ; Ayani I; Rodríguez-Sasiain JM; Gutiérrez G; Aguirre C
    Med Clin (Barc); 1998 Jun; 111(3):92-8. PubMed ID: 9706601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Special problems of adverse reaction assessment in Indonesia.
    Sihombing MP; Gan VH; Widya R
    Med Toxicol; 1986; 1 Suppl 1():95-8. PubMed ID: 3821434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pfizer's answer to Bengt Jarhult: joint challenge to develop methods for discovery of low-frequency adverse effects].
    Dahl E; Lindstrand G
    Lakartidningen; 2005 Feb 28-Mar 6; 102(9):665. PubMed ID: 15804040
    [No Abstract]   [Full Text] [Related]  

  • 46. [Coding of poisoning and side effects].
    Baberg HT; De Zeeuw J
    Med Klin (Munich); 2004 Jul; 99(7):398. PubMed ID: 15322720
    [No Abstract]   [Full Text] [Related]  

  • 47. [Adverse effects and the press].
    Noess K
    Tidsskr Nor Laegeforen; 1992 Aug; 112(19):2557. PubMed ID: 1412271
    [No Abstract]   [Full Text] [Related]  

  • 48. [Adverse effects as sensations].
    Haess K
    Tidsskr Nor Laegeforen; 1991 May; 111(14):1763-4. PubMed ID: 2063391
    [No Abstract]   [Full Text] [Related]  

  • 49. [Manna in history. IV. Manna in Spain].
    FOLCH ANDREU R
    Farmacognosia; 1955; 15(38):303-31. PubMed ID: 13330877
    [No Abstract]   [Full Text] [Related]  

  • 50. [A literature review of adverse drug reaction reports. Adverse drug effects can have genetical background].
    Rane A
    Lakartidningen; 2002 May; 99(20):2266-7. PubMed ID: 12082942
    [No Abstract]   [Full Text] [Related]  

  • 51. [Monitoring adverse drug effects in Czechoslovakia].
    Fousková H
    Cesk Farm; 1988 Oct; 37(8):344-5. PubMed ID: 3208301
    [No Abstract]   [Full Text] [Related]  

  • 52. [Drug by drug imputation of adverse effects in drug monitoring. Attempted comparison of different methods].
    Lagier G; Vincens M; Lefebure B; Frelon JH
    Therapie; 1983; 38(3):295-302. PubMed ID: 6612666
    [No Abstract]   [Full Text] [Related]  

  • 53. The Welsh Adverse Drug Reactions Scheme: experience of a UK regional monitoring centre.
    Houghton JE; Pinto Pereira LM; Woods FJ; Richens A; Routledge PA
    Adverse Drug React Toxicol Rev; 1996 Jun; 15(2):93-107. PubMed ID: 8836315
    [No Abstract]   [Full Text] [Related]  

  • 54. [Adverse effects and drug interactions].
    Perlík F
    Cas Lek Cesk; 2004; 143(2):110-3. PubMed ID: 15077574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Monitoring adverse drug effects in Spain].
    Laporte JR
    Therapie; 1987; 42(1):63-4. PubMed ID: 3590069
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.